1. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas

   • Torben Haerslev
   • Grete Krag Jacobsen
   • Karin Zedeler

   Report Pages: 101 - 113

2. Indications for hepatic ultrasonography in breast cancer staging and follow-up

   • Jean-Noël Bruneton
   • Catherine Balu-Maestro
   • Claire Granon

   Report Pages: 115 - 121

3. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma

   • Pierantonio Bevilacqua
   • Paolo Verderio
   • Giampietro Gasparini

   Report Pages: 123 - 133

4. Predicting axillary lymph node metastases in breast carcinoma patients

   • Poh Lian Choong
   • Christopher J. S. deSilva
   • Yianni Attikiouzel

   Report Pages: 135 - 149

5. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line

   • Shao-Yao Ying
   • Zhong Zhang

   Report Pages: 151 - 160

6. Elemental composition of bone minerals in women with breast cancer treated with adjuvant tamoxifen

   • J. A. Kalef-Ezra
   • N. Pavlidis
   • D. Glaros

   Report Pages: 161 - 168

7. The luteal heat cycle of the breast in disease

   • Hugh W. Simpson
   • Keith Griffiths
   • Atilla Turkes

   Report Pages: 169 - 178

8. Abnormal expression of MDM-2 in breast carcinomas

   • Carlos E. Bueso-Ramos
   • Taghi Manshouri
   • Maher Albitar

   Report Pages: 179 - 188

9. Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues

   • Orhan Canbolat
   • Ilker Durak
   • Serdar Öztürk

   Brief Communication Pages: 189 - 193